|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-20 04:00
Sentiment: Positive
TLDR The FDA approved Revolution Medicines’ drug Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma on August 26, 2026 The approval came months ahead of schedule, following Breakthrough Therapy, Orphan Drug, and priority review designations Phase 3 trial data showed patients on Rasonque lived a median of 13.2 months vs. 6.7 months on chemotherapy RVMD stock is [...] The post Revolution Medicines (RVMD) Stock Jumps as FDA Approves Its Pancreatic Cancer Pill Early appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central